Contrast-enhanced dynamic ultrasonography of the liver: Optimization of hepatic arterial phase in normal volunteers

Abdominal Imaging

Volumn 28, Issue 5, 2003, Pages 652-656

  Lee, K H ^a   Choi, B I ^a   Kim, K W ^a   Kim, J S ^a   Won, H J ^a   Han, J K ^a   Kim, S H ^a   Park, S H ^a  

^a Seoul National University Hospital   (South Korea)

Author keywords

Hepatic arterial phase; Levovist; Liver; Stimulated acoustic emission; Ultrasound contrast agents

Indexed keywords

SHU 508;

ADULT; ARTICLE; CONTRAST ENHANCEMENT; DIAGNOSTIC ACCURACY; ECHOGRAPHY; FEMALE; HEPATIC ARTERY; HUMAN; HUMAN EXPERIMENT; IMAGE ANALYSIS; IMAGE QUALITY; LIVER; MALE; NORMAL HUMAN; PORTAL VEIN; PRIORITY JOURNAL;

ADULT; CONTRAST MEDIA; FEMALE; HUMANS; IMAGE PROCESSING, COMPUTER-ASSISTED; LIVER; MALE; MIDDLE AGED; POLYSACCHARIDES;

EID: 0041923989     PISSN: 09428925     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00261-002-0092-5     Document Type: Article

References (31)

1. Puls I, Becker G, Maurer M, Mullges W. Cerebral arteriovenous transit time (CTT): a sonographic assessment of cerebral microcirculation using ultrasound contrast agents. Ultrasound Med Biol 1999;25:503-507
2. Wei K, Jayaweera AR, Firoozan S, et al. Quantification of myocardial blood flow with ultrasound-induced destruction of microbubbles administered as a constant venous infusion. Circulation 1998;97:473-483
3. Jayaweera AR, Edwards N, Glasheen WP, et al. In vivo myocardial kinetics of air-filled albumin microbubbles during myocardial contrast echocardiography. Comparison with radiolabeled red blood cells. Circ Res 1994;74:1157-1165
4. Kaul S, Kelly P, Oliner JD, et al. Assessment of regional myocardial blood flow with myocardial contrast two-dimensional echocardiography. J Am Coll Cardiol 1989;13:468-482
5. Rovai D, Nissen SE, Elion J, et al. Contrast echo washout curves from the left ventricle: application of basic principles of indicator-dilution theory and calculation of ejection fraction. J Am Coll Cardiol 1987;10:125-134
6. Albrecht T, Urbank A, Mahler M, et al. Prolongation and optimization of Doppler enhancement with a microbubble US contrast agent by using continuous infusion: preliminary experience. Radiology 1998;207:339-347
7. Bertolotto M, Dalla Palma L, Quaia E, Locatelli M. Characterization of unifocal liver lesions with pulse inversion harmonic imaging after Levovist injection: preliminary results. Eur Radiol 2000;10: 1369-1376
8. Burns PN, Wilson SR, Simpson DH. Pulse inversion imaging of liver blood flow: improved method for characterizing focal masses with microbubble contrast. Invest Radiol 2000;35:58-71
9. Ding H, Kudo M, Onda H, et al. Contrast-enhanced subtraction harmonic sonography for evaluating treatment response in patients with hepatocellular carcinoma. AJR 2001;176:661-666
10. Ding H, Kudo M, Onda H, et al. Hepatocellular carcinoma: depiction of tumor parenchymal flow with intermittent harmonic power Doppler US during the early hepatic arterial phase in dual-display mode. Radiology 2001;220:349-356
11. Harvey CJ, Blomley MJ, Eckersley RJ, et al. Hepatic malignancies: improved detection with pulse-inversion US in late phase of enhancement with SH U 508A-early experience. Radiology 2000;216: 903-908
12. Hauff P, Fritzsch T, Reinhardt M, et al. Delineation of experimental liver tumors in rabbits by a new ultrasound contrast agent and stimulated acoustic emission. Invest Radiol 1997;32:94-99
13. Heckemann RA, Cosgrove DO, Blomley MJ, et al. Liver lesions: intermittent second-harmonic gray-scale US can increase conspicuity with microbubble contrast material - early experience. Radiology 2000;216:592-596
14. Kim TK, Choi BI, Han JK, et al. Hepatic tumors: contrast agent-enhancement patterns with pulse-inversion harmonic US. Radiology 2000;216:411-417
15. Kim TK, Choi BI, Hong HS, et al. Improved imaging of hepatic metastases with delayed pulse inversion harmonic imaging using a contrast agent SH U 508A: preliminary study. Ultrasound Med Biol 2000;26:1439-1444
16. Meloni MF, Goldberg SN, Livraghi T, et al. Hepatocellular carcinoma treated with radiofrequency ablation: comparison of pulse inversion contrast-enhanced harmonic sonography, contrast-enhanced power Doppler sonography, and helical CT. AJR 2001;177: 375-380
17. Numata K, Tanaka K, Kiba T, et al. Using contrast-enhanced sonography to assess the effectiveness of transcatheter arterial embolization for hepatocellular carcinoma. AJR 2001;176:1199-1205
18. Tiemann K, Pohl C, Schlosser T, et al. Stimulated acoustic emission: pseudo-Doppler shifts seen during the destruction of nonmoving microbubbles. Ultrasound Med Biol 2000;26:1161-1167
19. Wilson SR, Burns PN, Muradali D, et al. Harmonic hepatic US with microbubble contrast agent: initial experience showing improved characterization of hemangioma, hepatocellular carcinoma, and metastasis. Radiology 2000;215:153-161
20. Blomley M, Albrecht T, Cosgrove DO, et al. Stimulated acoustic emission in liver parenchyma with Levovist. Lancet 1998;351:568
21. Blomley MJ, Albrecht T, Cosgrove DO, et al. Stimulated acoustic emission to image a late liver and spleen-specific phase of Levovist in normal volunteers and patients with and without liver disease. Ultrasound Med Biol 1999;25:1341-1352
22. Oliver JH III, Baron RL. Helical biphasic contrast-enhanced CT of the liver: technique, indications, interpretation, and pitfalls. Radiology 1996;201:1-14
23. Peterson MS, Baron RL, Murakami T. Hepatic malignancies: usefulness of acquisition of multiple arterial and portal venous phase images at dynamic gadolinium-enhanced MR imaging. Radiology 1996;201:337-345
24. Blomley MJ, Albrecht T, Cosgrove DO, et al. Improved imaging of liver metastases with stimulated acoustic emission in the late phase of enhancement with the US contrast agent SH U 508A: early experience. Radiology 1999;210:409-416
25. Uchimoto R, Niwa K, Eguchi H, et al. In vivo kinetics of microbubbles of SH U 508 A (Levovist): comparison with indocyanine green in rabbits. Ultrasound Med Biol 1999;25:1365-1370
26. Boos M, Scheffler K, Haselhorst R, et al. Arterial first pass gadolinium-CM dynamics as a function of several intravenous saline flush and Gd volumes. J Magn Resort Imaging 2001;13:568-576
27. Han JK, Kim AY, Lee KY, et al. Factors influencing vascular and hepatic enhancement at CT: experimental study on injection protocol using a canine model. J Comput Assist Tomogr 2000;24:400-406
28. Bae KT, Heiken JP, Brink JA. Aortic and hepatic contrast medium enhancement at CT. Part 1. Prediction with a computer model. Radiology 1998;207:647-655
29. Rubin DN, Thomas JD. New imaging technology: measurement of myocardial perfusion by contrast echocardiography. Coron Artery Dis 2000;11:221-226
30. Postert T, Braun B, Meves S, et al. Contrast-enhanced transcranial color-coded sonography in acute hemispheric brain infarction. Stroke 1999;30:1819-1826
31. Caiati C, Montaldo C, Zedda N, et al. New noninvasive method for coronary flow reserve assessment: contrast-enhanced transthoracic second harmonic echo Doppler. Circulation 1999;99:771-778